Abstract:Sex and age associated differences in the tumor immune microenvironment of non-muscle invasive bladder (NMIBC) cancer and associated clinical outcomes are emerging indicators of treatment outcomes. The incidence of urothelial carcinoma of the bladder is four times higher in males than females; however, females tend to present with a more aggressive disease, a poorer response to immunotherapy and suffer worse clinical outcomes. Recent findings have demonstrated sex differences in the tumor immune microenvironment of non-muscle invasive and muscle invasive bladder cancer and associated clinical outcomes. However, a significant gap in knowledge remains with respect to the current pre-clinical modeling approaches to more precisely recapitulate these differences towards improved therapeutic design. Given the similarities in mucosal immune physiology between humans and mice, we evaluated the sex and age-related immune alterations in healthy murine bladders. Bulk-RNA sequencing and multiplex immunofluorescence-based spatial immune profiling of healthy murine bladders from male and female mice of age groups spanning young to old showed a highly altered immune landscape that exhibited sex and age associated differences, particularly in the context of B cell mediated responses. Spatial profiling of healthy bladders, using markers specific to macrophages, T cells, B cells, activated dendritic cells, high endothelial venules, myeloid cells and the PD-L1 immune checkpoint showed sex and age associated differences. Bladders from healthy older female mice also showed a higher presence of tertiary lymphoid structures (TLSs) compared to both young female and male equivalents. Spatial immune profiling of N -butyl- N -(4-hydroxybutyl) nitrosamine (BBN) carcinogen exposed male and female bladders from young and old mice revealed a similar frequency of TLS formation, sex differences in the bladder immune microenvironment and, age associated differences in latency of tumor induction. These findings support the incorporation of sex and age as factors in pre-clinical modeling of bladder cancer and will potentially advance the field of immunotherapeutic drug development to improve clinical outcomes.

Sexual dimorphism in bladder cancer: a review of etiology, biology, diagnosis, and outcomes

Advances in sex disparities for cancer immunotherapy: unveiling the dilemma of Yin and Yang

Sex Disparities in Bladder Cancer Diagnosis and Treatment

Reproductive and Hormonal Factors and Bladder Cancer Risk: a Prospective Study and Meta-Analysis

Sex Dimorphism in the Tumor Microenvironment - from Bench to Bedside and Back

An Integrative Study to Investigate Sex-Specific Biomarkers in Bladder Cancer Patients

Connecting the Mechanisms of Tumor Sex Differences with Cancer Therapy.

Sex differences in the aging murine urinary bladder and influence on the tumor immune microenvironment of a carcinogen-induced model of bladder cancer

Sex differences in colorectal cancer: with a focus on sex hormone–gut microbiome axis

Sexual dimorphism in cancer: insights from transcriptional signatures in kidney tissue and renal cell carcinoma

The influence of age and sex on the pre-treatment immune microenvironment of a carcinogen induced murine model of bladder cancer

Gender Dimorphism in Survival of Patients with Lymph Node Metastasis of Bladder Cancer

Advances in relationship between smoking and bladder cancer

Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity

Multidisciplinary management of sexual and gender minorities with bladder cancer

Comprehensive Characterization of Molecular Differences in Cancer Between Male and Female Patients.

Sex difference in human diseases: mechanistic insights and clinical implications

Recent Progress in Research of the Relationship Between Bladder Cancer and Sexual Hormone Receptors

The effect of patient sex on the efficacy and safety of anticancer immunotherapy

Sexual Dimorphism in Colon Cancer

Comprehensive Characterization of Tumor Microenvironment Differences in Cancer between Male and Female Patients